scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046181199 |
P356 | DOI | 10.1038/SJ.ONC.1203261 |
P698 | PubMed publication ID | 10644994 |
P5875 | ResearchGate publication ID | 12669549 |
P50 | author | Joseph R Slupsky | Q38322946 |
P2093 | author name string | Block C | |
Rapp UR | |||
Herrmann C | |||
Weber CK | |||
Schuler M | |||
P2860 | cites work | The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus | Q22254864 |
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 | Q24309607 | ||
Ras/Rap effector specificity determined by charge reversal | Q24315941 | ||
The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue | Q24323252 | ||
The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation | Q24522806 | ||
Activation of ternary complex factor Elk-1 by MAP kinases | Q24564310 | ||
Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun | Q28283776 | ||
Two distinct Raf domains mediate interaction with Ras | Q28300500 | ||
The ins and outs of Raf kinases | Q28307284 | ||
Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases | Q28609156 | ||
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane | Q29618478 | ||
Activation of Raf as a result of recruitment to the plasma membrane | Q29618481 | ||
A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function | Q30454014 | ||
Taxonomy and function of C1 protein kinase C homology domains | Q36280307 | ||
Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase | Q38298684 | ||
Analysis of the ERK-stimulated ETS transcription factor ER81. | Q40018533 | ||
Genetics of signal transduction in invertebrates | Q40757559 | ||
Discrimination of amino acids mediating Ras binding from noninteracting residues affecting raf activation by double mutant analysis | Q41075527 | ||
Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. | Q41092757 | ||
Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor | Q41214472 | ||
How Ras-related proteins talk to their effectors | Q41331175 | ||
Ras and its effectors | Q41434222 | ||
Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase | Q42820729 | ||
Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. | Q45971337 | ||
Conspiracy theory: RAS and RAF do not act alone | Q46050993 | ||
Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo | Q71011188 | ||
Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells | Q71118388 | ||
A novel strategy for the immunological tagging of cDNA constructs | Q71605954 | ||
Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase | Q77195536 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 169-176 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes | |
P478 | volume | 19 |
Q38618036 | A-Raf: A new star of the family of raf kinases |
Q35117306 | Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. |
Q34728330 | An old kinase on a new path: Raf and apoptosis |
Q40749465 | Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. |
Q40738261 | Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. |
Q40106302 | B- and C-RAF display essential differences in their binding to Ras: the isotype-specific N terminus of B-RAF facilitates Ras binding |
Q24791830 | Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis |
Q34293560 | Development of anticancer drugs targeting the MAP kinase pathway |
Q42416308 | Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation |
Q50643518 | Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration. |
Q39260997 | Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes |
Q50917827 | Genomic insights into head and neck cancer. |
Q28203433 | Identification and genetic analysis of human and mouse activated Cdc42 interacting protein-4 isoforms |
Q41792391 | Integrated RAS signaling defined by parallel NMR detection of effectors and regulators. |
Q35635353 | JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis |
Q40790669 | P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. |
Q45065372 | Piconewton-Scale Analysis of Ras-BRaf Signal Transduction with Single-Molecule Force Spectroscopy |
Q42799900 | Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras |
Q24316181 | Raf family kinases: old dogs have learned new tricks |
Q41887999 | Raf-1 regulates Rho signaling and cell migration |
Q35459718 | Rafs constitute a nodal point in the regulation of embryonic endothelial progenitor cell growth and differentiation |
Q37822317 | Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development |
Q47144786 | SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a. |
Q34348449 | Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors |
Q54108531 | Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth. |
Q35166852 | Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. |
Q34358419 | Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis |
Q35020561 | Targeting the Raf kinase cascade in cancer therapy--novel molecular targets and therapeutic strategies |
Q36283341 | The Kinase Activity-deficient Isoform of the Protein Araf Antagonizes Ras/Mitogen-activated Protein Kinase (Ras/MAPK) Signaling in the Zebrafish Embryo |
Q29620153 | The RAF proteins take centre stage |
Q34605237 | The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia |
Search more.